Geneoscopy, Inc
St. Louis, US · 3 known investors
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
AB
Andrew BarnellChief Executive Officer & Co-founder
EB
Erica BarnellCo-founder
Investors · 3
In the news
- Geneoscopy Raises $105M C Round | Cultivation Capitalcultivationcapital.com · 2025
- Cancer test developer Geneoscoy closes $105M Series C funding round - St. Louis Business Journalbizjournals.com · 2025
- Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Geneoscopy - Transforming Gastrointestinal Healthgeneoscopy.com · 2025
- Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Testsbusinesswire.com · 2025
- Geneoscopy - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Geneoscopy Raises $6.9M in Series A Funding - FinSMEsfinsmes.com · 2019